Francesco Latrofa

4.9k total citations
94 papers, 3.6k citations indexed

About

Francesco Latrofa is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Francesco Latrofa has authored 94 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Pathology and Forensic Medicine and 15 papers in Molecular Biology. Recurrent topics in Francesco Latrofa's work include Thyroid Disorders and Treatments (51 papers), Thyroid Cancer Diagnosis and Treatment (33 papers) and Ophthalmology and Eye Disorders (28 papers). Francesco Latrofa is often cited by papers focused on Thyroid Disorders and Treatments (51 papers), Thyroid Cancer Diagnosis and Treatment (33 papers) and Ophthalmology and Eye Disorders (28 papers). Francesco Latrofa collaborates with scholars based in Italy, United States and United Kingdom. Francesco Latrofa's co-authors include Paolo Vitti, Basil Rapoport, Sandra M. McLachlan, Luca Chiovato, Debora Ricci, Chun‐Rong Chen, Pavel N. Pichurin, Alessandro Brancatella, Aldo Pinchera and Nicola Viola and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Francesco Latrofa

91 papers receiving 3.5k citations

Peers

Francesco Latrofa

EDM

PFM

ID

IMMUN

MB

Mario Salvi Italy

Alfredo Campennì Italy

Michele Marinò Italy

Ilaria Ruffilli Italy

Klaus‐Martin Schulte Germany

Takumi Kudo Japan

Kristien Boelaert United Kingdom

Thorsten Wiech Germany

Emese Kiss Hungary

Jaeduk Yoshimura Noh Japan

Mario Salvi Italy

Francesco Latrofa

3.4k ×1.3

EDM

3.6k ×3.5

PFM

222 ×0.4

ID

387 ×0.8

IMMUN

356 ×0.9

MB

Citations per year, relative to Francesco Latrofa Francesco Latrofa (= 1×) peers Mario Salvi

Countries citing papers authored by Francesco Latrofa

Since Specialization

Citations

This map shows the geographic impact of Francesco Latrofa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Latrofa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Latrofa more than expected).

Fields of papers citing papers by Francesco Latrofa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Latrofa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Latrofa. The network helps show where Francesco Latrofa may publish in the future.

Co-authorship network of co-authors of Francesco Latrofa

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Latrofa. A scholar is included among the top collaborators of Francesco Latrofa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Latrofa. Francesco Latrofa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sabini, Elena, Francesca Menconi, Chiara Posarelli, et al.. (2025). Serum levels of rapamycin predict the response of Graves’ orbitopathy to sirolimus. Journal of Endocrinological Investigation. 48(7). 1677–1682. 2 indexed citations

2.

Dottore, Giovanna Rotondo, Francesca Menconi, Roberto Rocchi, et al.. (2024). Role of genetics and epigenetics in Graves’ orbitopathy. European Thyroid Journal. 13(6). 4 indexed citations

3.

Prencipe, Giuseppe, et al.. (2024). Pathways to democratized healthcare: Envisioning human-centered AI-as-a-service for customized diagnosis and rehabilitation. Artificial Intelligence in Medicine. 151. 102850–102850. 10 indexed citations

4.

Sgrò, Daniele, Piercarlo Rossi, Paolo Piaggi, et al.. (2023). Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib. Journal of the Endocrine Society. 7(8). bvad084–bvad084. 1 indexed citations

5.

Valerio, Laura, Alessandro Prete, Ferruccio Santini, et al.. (2023). Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination. Endocrine. 81(3). 455–458.

6.

Lanzolla, Giulia, Debora Ricci, Elena Sabini, et al.. (2020). Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study. Journal of Endocrinological Investigation. 43(12). 1759–1768. 21 indexed citations

7.

Marinò, Michele, Ilaria Ionni, Giulia Lanzolla, et al.. (2019). Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis. Journal of Endocrinological Investigation. 43(4). 401–411. 39 indexed citations

8.

Brancatella, Alessandro, Nicola Viola, Sandra Brogioni, et al.. (2019). Graves’ Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature. European Thyroid Journal. 8(4). 192–195. 46 indexed citations

9.

Sabini, Elena, Eleonora Sisti, B. Coco, et al.. (2016). Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy. Journal of Endocrinological Investigation. 39(11). 1323–1327. 8 indexed citations

10.

Tomisti, Luca, Claudio Urbani, Gian Paolo Rossi, et al.. (2016). The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis. Journal of Endocrinological Investigation. 39(5). 585–591. 15 indexed citations

11.

Sisti, Eleonora, B. Coco, Francesca Menconi, et al.. (2015). Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy. Thyroid. 25(7). 846–850. 26 indexed citations

12.

Sisti, Eleonora, Francesca Menconi, Maria Antonietta Profilo, et al.. (2015). Long-term outcome of Graves’ orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy. Journal of Endocrinological Investigation. 38(6). 661–668. 29 indexed citations

13.

Marinò, Michele, Francesco Latrofa, Francesca Menconi, Luca Chiovato, & Paolo Vitti. (2014). An update on the medical treatment of Graves’ hyperthyroidism. Journal of Endocrinological Investigation. 37(11). 1041–1048. 31 indexed citations

14.

Latrofa, Francesco, Debora Ricci, Lucia Montanelli, et al.. (2014). Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope. Journal of Endocrinological Investigation. 35(8). 712–714. 15 indexed citations

15.

Menconi, Francesca, Maria Antonietta Profilo, Marenza Leo, et al.. (2013). Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited. Thyroid. 24(1). 60–66. 83 indexed citations

16.

Latrofa, Francesco, Debora Ricci, Lucia Montanelli, et al.. (2012). Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin. The Journal of Clinical Endocrinology & Metabolism. 97(7). 2380–2387. 61 indexed citations

17.

Latrofa, Francesco, et al.. (2009). Pathogenetic and clinical aspects of autoimmune thyroiditis. Experimental and Clinical Endocrinology & Diabetes. 107(S 03). S79–S83. 2 indexed citations

18.

Latrofa, Francesco, Debora Ricci, Paolo Vitti, et al.. (2009). Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto’s thyroiditis: evidence against a major effect of age and genetic background on B‐cell epitopes. Clinical Endocrinology. 73(1). 110–113. 19 indexed citations

19.

Chazenbalk, Gregorio D., Pavel N. Pichurin, Chun‐Rong Chen, et al.. (2002). Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. Journal of Clinical Investigation. 110(2). 209–217. 115 indexed citations

20.

Chazenbalk, Gregorio D., Pavel N. Pichurin, Chun‐Rong Chen, et al.. (2002). Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. Journal of Clinical Investigation. 110(2). 209–217. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact